Mirae Asset Global Investments Co. Ltd. Sells 77,218 Shares of R1 RCM Inc. (NASDAQ:RCM)

Mirae Asset Global Investments Co. Ltd. lessened its stake in shares of R1 RCM Inc. (NASDAQ:RCM - Free Report) by 25.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 225,430 shares of the healthcare provider's stock after selling 77,218 shares during the quarter. Mirae Asset Global Investments Co. Ltd. owned about 0.05% of R1 RCM worth $2,383,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of RCM. New York State Teachers Retirement System raised its position in R1 RCM by 2.4% during the 4th quarter. New York State Teachers Retirement System now owns 139,921 shares of the healthcare provider's stock worth $1,479,000 after buying an additional 3,300 shares during the last quarter. ANTIPODES PARTNERS Ltd grew its holdings in shares of R1 RCM by 429.5% during the fourth quarter. ANTIPODES PARTNERS Ltd now owns 5,623 shares of the healthcare provider's stock worth $59,000 after buying an additional 4,561 shares in the last quarter. Pacer Advisors Inc. grew its holdings in shares of R1 RCM by 79.1% during the fourth quarter. Pacer Advisors Inc. now owns 29,603 shares of the healthcare provider's stock worth $313,000 after buying an additional 13,071 shares in the last quarter. Salem Investment Counselors Inc. acquired a new stake in shares of R1 RCM in the fourth quarter worth approximately $61,000. Finally, Vanguard Group Inc. boosted its position in shares of R1 RCM by 5.6% in the third quarter. Vanguard Group Inc. now owns 17,940,792 shares of the healthcare provider's stock worth $270,368,000 after acquiring an additional 947,310 shares during the last quarter. Hedge funds and other institutional investors own 61.10% of the company's stock.

R1 RCM Stock Performance

R1 RCM stock traded down $0.03 during mid-day trading on Friday, hitting $11.99. 1,952,226 shares of the company were exchanged, compared to its average volume of 3,750,215. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.83 and a current ratio of 1.83. The business has a fifty day moving average of $12.73 and a 200 day moving average of $11.53. R1 RCM Inc. has a 1-year low of $8.87 and a 1-year high of $18.70.

Insiders Place Their Bets

In other R1 RCM news, President John M. Sparby sold 10,046 shares of the business's stock in a transaction that occurred on Thursday, March 7th. The stock was sold at an average price of $14.33, for a total transaction of $143,959.18. Following the transaction, the president now owns 265,986 shares of the company's stock, valued at approximately $3,811,579.38. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 37.00% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the stock. Guggenheim dropped their price objective on shares of R1 RCM from $17.00 to $15.00 and set a "buy" rating on the stock in a research note on Friday, April 5th. Cantor Fitzgerald reissued an "overweight" rating and set a $20.00 price target on shares of R1 RCM in a report on Wednesday, April 10th. SVB Leerink initiated coverage on shares of R1 RCM in a report on Monday, February 26th. They set an "outperform" rating and a $14.00 price target for the company. Morgan Stanley reaffirmed an "overweight" rating and issued a $17.00 price objective on shares of R1 RCM in a report on Tuesday, March 26th. Finally, Evercore ISI reaffirmed an "in-line" rating and issued a $16.00 price objective (up previously from $12.00) on shares of R1 RCM in a report on Wednesday, February 28th. Five investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $16.87.

R1 RCM Profile

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.